The FDA approval of KIRSTY expands Biocon Biologics’ biosimilar insulin portfolio, which also includes the first approved interchangeable biosimilar, Semglee® (Insulin Glargine-yfgn Injection).

People with type 1 diabetes rely on strict routines to keep their blood sugar levels stable. Smart insulins promise relief from the mental toll of daily glucose monitoring and management.

Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of Biocon announced that US FDA has approved Kirsty (insulin aspart-xjhz), 100 units/mL as the first and only ...

Key Takeaways An insulin nasal spray might be a potential treatment for Alzheimer’s diseaseBrain scans show insulin travels to 11 key brain regions associated with memory and thoughtPeople with ...

BRIDGEWATER, N.J., United States and BENGALURU, Karnataka, India, July 15, 2025 (GLOBE NEWSWIRE) -- Biocon Biologics Ltd (BBL), a fully integrated global biosimilars company and subsidiary of ...

The FDA approval of KIRSTY expands Biocon Biologics' biosimilar insulin portfolio, which also includes the first approved interchangeable biosimilar, Semglee® (Insulin Glargine-yfgn Injection).

Insulin aspart injection: Novo Nordisk will discontinue unbranded insulin aspart injection products including FlexPen pens, PenFill cartridges and 10-milliliter vials by Dec. 31, 2025.

NovoLog is a prescription drug used to treat diabetes. Learn about the drug’s dosages, forms, strength, and more.

Trying to solve the Wordle today? If you're stuck, we've got a few hints that will help you keep your Wordle streak alive.

Semaglutide is the active ingredient in Ozempic and Wegovy. Here's what you need to know, including which variation is FDA approved for weight loss.